Global Mucopolysaccharidosis II Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Mucopolysaccharidosis II market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Mucopolysaccharidosis II is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mucopolysaccharidosis II is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mucopolysaccharidosis II is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mucopolysaccharidosis II players cover Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Mucopolysaccharidosis II Industry Forecast” looks at past sales and reviews total world Mucopolysaccharidosis II sales in 2024, providing a comprehensive analysis by region and market sector of projected Mucopolysaccharidosis II sales for 2025 through 2031. With Mucopolysaccharidosis II sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mucopolysaccharidosis II industry.
This Insight Report provides a comprehensive analysis of the global Mucopolysaccharidosis II landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mucopolysaccharidosis II portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mucopolysaccharidosis II market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mucopolysaccharidosis II and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mucopolysaccharidosis II.
This report presents a comprehensive overview, market shares, and growth opportunities of Mucopolysaccharidosis II market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mucopolysaccharidosis II market?
What factors are driving Mucopolysaccharidosis II market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mucopolysaccharidosis II market opportunities vary by end market size?
How does Mucopolysaccharidosis II break out by Type, by Application?
The global Mucopolysaccharidosis II market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Mucopolysaccharidosis II is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Mucopolysaccharidosis II is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Mucopolysaccharidosis II is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Mucopolysaccharidosis II players cover Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Mucopolysaccharidosis II Industry Forecast” looks at past sales and reviews total world Mucopolysaccharidosis II sales in 2024, providing a comprehensive analysis by region and market sector of projected Mucopolysaccharidosis II sales for 2025 through 2031. With Mucopolysaccharidosis II sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mucopolysaccharidosis II industry.
This Insight Report provides a comprehensive analysis of the global Mucopolysaccharidosis II landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mucopolysaccharidosis II portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mucopolysaccharidosis II market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mucopolysaccharidosis II and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mucopolysaccharidosis II.
This report presents a comprehensive overview, market shares, and growth opportunities of Mucopolysaccharidosis II market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- JR-141
- EGT-301
- DUOC-01
- AGT-182
- JR-032
- Others
- Hospital
- Clinic
- Research Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Alexion Pharmaceuticals, Inc.
- AngioChem Inc.
- ArmaGen Inc.
- Bioasis Technologies Inc.
- Green Cross Corporation
- Inventiva
- JCR Pharmaceuticals Co., Ltd.
- Laboratorios Del Dr. Esteve S.A.
- RegenxBio Inc.
- Sangamo BioSciences, Inc.
- Takeda
What is the 10-year outlook for the global Mucopolysaccharidosis II market?
What factors are driving Mucopolysaccharidosis II market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mucopolysaccharidosis II market opportunities vary by end market size?
How does Mucopolysaccharidosis II break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mucopolysaccharidosis II Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mucopolysaccharidosis II by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mucopolysaccharidosis II by Country/Region, 2020, 2024 & 2031
2.2 Mucopolysaccharidosis II Segment by Type
2.2.1 JR-141
2.2.2 EGT-301
2.2.3 DUOC-01
2.2.4 AGT-182
2.2.5 JR-032
2.2.6 Others
2.3 Mucopolysaccharidosis II Sales by Type
2.3.1 Global Mucopolysaccharidosis II Sales Market Share by Type (2020-2025)
2.3.2 Global Mucopolysaccharidosis II Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mucopolysaccharidosis II Sale Price by Type (2020-2025)
2.4 Mucopolysaccharidosis II Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.4.4 Others
2.5 Mucopolysaccharidosis II Sales by Application
2.5.1 Global Mucopolysaccharidosis II Sale Market Share by Application (2020-2025)
2.5.2 Global Mucopolysaccharidosis II Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mucopolysaccharidosis II Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mucopolysaccharidosis II Breakdown Data by Company
3.1.1 Global Mucopolysaccharidosis II Annual Sales by Company (2020-2025)
3.1.2 Global Mucopolysaccharidosis II Sales Market Share by Company (2020-2025)
3.2 Global Mucopolysaccharidosis II Annual Revenue by Company (2020-2025)
3.2.1 Global Mucopolysaccharidosis II Revenue by Company (2020-2025)
3.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Company (2020-2025)
3.3 Global Mucopolysaccharidosis II Sale Price by Company
3.4 Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mucopolysaccharidosis II Product Location Distribution
3.4.2 Players Mucopolysaccharidosis II Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
4.1 World Historic Mucopolysaccharidosis II Market Size by Geographic Region (2020-2025)
4.1.1 Global Mucopolysaccharidosis II Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mucopolysaccharidosis II Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mucopolysaccharidosis II Market Size by Country/Region (2020-2025)
4.2.1 Global Mucopolysaccharidosis II Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mucopolysaccharidosis II Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mucopolysaccharidosis II Sales Growth
4.4 APAC Mucopolysaccharidosis II Sales Growth
4.5 Europe Mucopolysaccharidosis II Sales Growth
4.6 Middle East & Africa Mucopolysaccharidosis II Sales Growth
5 AMERICAS
5.1 Americas Mucopolysaccharidosis II Sales by Country
5.1.1 Americas Mucopolysaccharidosis II Sales by Country (2020-2025)
5.1.2 Americas Mucopolysaccharidosis II Revenue by Country (2020-2025)
5.2 Americas Mucopolysaccharidosis II Sales by Type (2020-2025)
5.3 Americas Mucopolysaccharidosis II Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mucopolysaccharidosis II Sales by Region
6.1.1 APAC Mucopolysaccharidosis II Sales by Region (2020-2025)
6.1.2 APAC Mucopolysaccharidosis II Revenue by Region (2020-2025)
6.2 APAC Mucopolysaccharidosis II Sales by Type (2020-2025)
6.3 APAC Mucopolysaccharidosis II Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mucopolysaccharidosis II by Country
7.1.1 Europe Mucopolysaccharidosis II Sales by Country (2020-2025)
7.1.2 Europe Mucopolysaccharidosis II Revenue by Country (2020-2025)
7.2 Europe Mucopolysaccharidosis II Sales by Type (2020-2025)
7.3 Europe Mucopolysaccharidosis II Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mucopolysaccharidosis II by Country
8.1.1 Middle East & Africa Mucopolysaccharidosis II Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2020-2025)
8.2 Middle East & Africa Mucopolysaccharidosis II Sales by Type (2020-2025)
8.3 Middle East & Africa Mucopolysaccharidosis II Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II
10.3 Manufacturing Process Analysis of Mucopolysaccharidosis II
10.4 Industry Chain Structure of Mucopolysaccharidosis II
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mucopolysaccharidosis II Distributors
11.3 Mucopolysaccharidosis II Customer
12 WORLD FORECAST REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
12.1 Global Mucopolysaccharidosis II Market Size Forecast by Region
12.1.1 Global Mucopolysaccharidosis II Forecast by Region (2026-2031)
12.1.2 Global Mucopolysaccharidosis II Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mucopolysaccharidosis II Forecast by Type (2026-2031)
12.7 Global Mucopolysaccharidosis II Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Alexion Pharmaceuticals, Inc.
13.1.1 Alexion Pharmaceuticals, Inc. Company Information
13.1.2 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alexion Pharmaceuticals, Inc. Main Business Overview
13.1.5 Alexion Pharmaceuticals, Inc. Latest Developments
13.2 AngioChem Inc.
13.2.1 AngioChem Inc. Company Information
13.2.2 AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AngioChem Inc. Main Business Overview
13.2.5 AngioChem Inc. Latest Developments
13.3 ArmaGen Inc.
13.3.1 ArmaGen Inc. Company Information
13.3.2 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ArmaGen Inc. Main Business Overview
13.3.5 ArmaGen Inc. Latest Developments
13.4 Bioasis Technologies Inc.
13.4.1 Bioasis Technologies Inc. Company Information
13.4.2 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bioasis Technologies Inc. Main Business Overview
13.4.5 Bioasis Technologies Inc. Latest Developments
13.5 Green Cross Corporation
13.5.1 Green Cross Corporation Company Information
13.5.2 Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
13.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Green Cross Corporation Main Business Overview
13.5.5 Green Cross Corporation Latest Developments
13.6 Inventiva
13.6.1 Inventiva Company Information
13.6.2 Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
13.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Inventiva Main Business Overview
13.6.5 Inventiva Latest Developments
13.7 JCR Pharmaceuticals Co., Ltd.
13.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
13.7.2 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
13.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
13.7.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
13.8 Laboratorios Del Dr. Esteve S.A.
13.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
13.8.2 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
13.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Laboratorios Del Dr. Esteve S.A. Main Business Overview
13.8.5 Laboratorios Del Dr. Esteve S.A. Latest Developments
13.9 RegenxBio Inc.
13.9.1 RegenxBio Inc. Company Information
13.9.2 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 RegenxBio Inc. Main Business Overview
13.9.5 RegenxBio Inc. Latest Developments
13.10 Sangamo BioSciences, Inc.
13.10.1 Sangamo BioSciences, Inc. Company Information
13.10.2 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sangamo BioSciences, Inc. Main Business Overview
13.10.5 Sangamo BioSciences, Inc. Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
13.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Mucopolysaccharidosis II Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mucopolysaccharidosis II Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of JR-141
Table 4. Major Players of EGT-301
Table 5. Major Players of DUOC-01
Table 6. Major Players of AGT-182
Table 7. Major Players of JR-032
Table 8. Major Players of Others
Table 9. Global Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 10. Global Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Table 11. Global Mucopolysaccharidosis II Revenue byType (2020-2025) & ($ million)
Table 12. Global Mucopolysaccharidosis II Revenue Market Share byType (2020-2025)
Table 13. Global Mucopolysaccharidosis II Sale Price byType (2020-2025) & (USD/Pcs)
Table 14. Global Mucopolysaccharidosis II Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Mucopolysaccharidosis II Sale Market Share by Application (2020-2025)
Table 16. Global Mucopolysaccharidosis II Revenue by Application (2020-2025) & ($ million)
Table 17. Global Mucopolysaccharidosis II Revenue Market Share by Application (2020-2025)
Table 18. Global Mucopolysaccharidosis II Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Mucopolysaccharidosis II Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Mucopolysaccharidosis II Sales Market Share by Company (2020-2025)
Table 21. Global Mucopolysaccharidosis II Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Company (2020-2025)
Table 23. Global Mucopolysaccharidosis II Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution and Sales Area
Table 25. Players Mucopolysaccharidosis II Products Offered
Table 26. Mucopolysaccharidosis II Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Mucopolysaccharidosis II Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Mucopolysaccharidosis II Sales Market Share Geographic Region (2020-2025)
Table 31. Global Mucopolysaccharidosis II Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Mucopolysaccharidosis II Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Mucopolysaccharidosis II Sales Market Share by Country/Region (2020-2025)
Table 35. Global Mucopolysaccharidosis II Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Mucopolysaccharidosis II Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Mucopolysaccharidosis II Sales Market Share by Country (2020-2025)
Table 39. Americas Mucopolysaccharidosis II Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 41. Americas Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Mucopolysaccharidosis II Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Mucopolysaccharidosis II Sales Market Share by Region (2020-2025)
Table 44. APAC Mucopolysaccharidosis II Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 46. APAC Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Mucopolysaccharidosis II Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 50. Europe Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis II
Table 56. Key Market Challenges & Risks of Mucopolysaccharidosis II
Table 57. Key IndustryTrends of Mucopolysaccharidosis II
Table 58. Mucopolysaccharidosis II Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Mucopolysaccharidosis II Distributors List
Table 61. Mucopolysaccharidosis II Customer List
Table 62. Global Mucopolysaccharidosis II SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. Global Mucopolysaccharidosis II RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Americas Mucopolysaccharidosis II SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Mucopolysaccharidosis II Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. APAC Mucopolysaccharidosis II SalesForecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Mucopolysaccharidosis II Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 68. Europe Mucopolysaccharidosis II SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Mucopolysaccharidosis II RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Mucopolysaccharidosis II SalesForecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Mucopolysaccharidosis II RevenueForecast by Country (2026-2031) & ($ millions)
Table 72. Global Mucopolysaccharidosis II SalesForecast byType (2026-2031) & (K Pcs)
Table 73. Global Mucopolysaccharidosis II RevenueForecast byType (2026-2031) & ($ millions)
Table 74. Global Mucopolysaccharidosis II SalesForecast by Application (2026-2031) & (K Pcs)
Table 75. Global Mucopolysaccharidosis II RevenueForecast by Application (2026-2031) & ($ millions)
Table 76. Alexion Pharmaceuticals, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 77. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 78. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Alexion Pharmaceuticals, Inc. Main Business
Table 80. Alexion Pharmaceuticals, Inc. Latest Developments
Table 81. AngioChem Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 82. AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 83. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. AngioChem Inc. Main Business
Table 85. AngioChem Inc. Latest Developments
Table 86. ArmaGen Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 87. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 88. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. ArmaGen Inc. Main Business
Table 90. ArmaGen Inc. Latest Developments
Table 91. BioasisTechnologies Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 92. BioasisTechnologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 93. BioasisTechnologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. BioasisTechnologies Inc. Main Business
Table 95. BioasisTechnologies Inc. Latest Developments
Table 96. Green Cross Corporation Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 97. Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
Table 98. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Green Cross Corporation Main Business
Table 100. Green Cross Corporation Latest Developments
Table 101. Inventiva Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 102. Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
Table 103. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Inventiva Main Business
Table 105. Inventiva Latest Developments
Table 106. JCR Pharmaceuticals Co., Ltd. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 107. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 108. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. JCR Pharmaceuticals Co., Ltd. Main Business
Table 110. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 111. Laboratorios Del Dr. Esteve S.A. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 112. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 113. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Laboratorios Del Dr. Esteve S.A. Main Business
Table 115. Laboratorios Del Dr. Esteve S.A. Latest Developments
Table 116. RegenxBio Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 117. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 118. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. RegenxBio Inc. Main Business
Table 120. RegenxBio Inc. Latest Developments
Table 121. Sangamo BioSciences, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 122. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 123. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. Sangamo BioSciences, Inc. Main Business
Table 125. Sangamo BioSciences, Inc. Latest Developments
Table 126.Takeda Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 127.Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
Table 128.Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 129.Takeda Main Business
Table 130.Takeda Latest Developments
LIST OFFIGURES
Figure 1. Picture of Mucopolysaccharidosis II
Figure 2. Mucopolysaccharidosis II Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mucopolysaccharidosis II Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Mucopolysaccharidosis II Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mucopolysaccharidosis II Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mucopolysaccharidosis II Sales Market Share by Country/Region (2024)
Figure 10. Mucopolysaccharidosis II Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of JR-141
Figure 12. Product Picture of EGT-301
Figure 13. Product Picture of DUOC-01
Figure 14. Product Picture of AGT-182
Figure 15. Product Picture of JR-032
Figure 16. Product Picture of Others
Figure 17. Global Mucopolysaccharidosis II Sales Market Share byType in 2025
Figure 18. Global Mucopolysaccharidosis II Revenue Market Share byType (2020-2025)
Figure 19. Mucopolysaccharidosis II Consumed in Hospital
Figure 20. Global Mucopolysaccharidosis II Market: Hospital (2020-2025) & (K Pcs)
Figure 21. Mucopolysaccharidosis II Consumed in Clinic
Figure 22. Global Mucopolysaccharidosis II Market: Clinic (2020-2025) & (K Pcs)
Figure 23. Mucopolysaccharidosis II Consumed in Research Center
Figure 24. Global Mucopolysaccharidosis II Market: Research Center (2020-2025) & (K Pcs)
Figure 25. Mucopolysaccharidosis II Consumed in Others
Figure 26. Global Mucopolysaccharidosis II Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Mucopolysaccharidosis II Sale Market Share by Application (2024)
Figure 28. Global Mucopolysaccharidosis II Revenue Market Share by Application in 2025
Figure 29. Mucopolysaccharidosis II Sales by Company in 2025 (K Pcs)
Figure 30. Global Mucopolysaccharidosis II Sales Market Share by Company in 2025
Figure 31. Mucopolysaccharidosis II Revenue by Company in 2025 ($ millions)
Figure 32. Global Mucopolysaccharidosis II Revenue Market Share by Company in 2025
Figure 33. Global Mucopolysaccharidosis II Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 36. Americas Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 37. APAC Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 38. APAC Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 39. Europe Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 40. Europe Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 43. Americas Mucopolysaccharidosis II Sales Market Share by Country in 2025
Figure 44. Americas Mucopolysaccharidosis II Revenue Market Share by Country (2020-2025)
Figure 45. Americas Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 46. Americas Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 47. United States Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Mucopolysaccharidosis II Sales Market Share by Region in 2025
Figure 52. APAC Mucopolysaccharidosis II Revenue Market Share by Region (2020-2025)
Figure 53. APAC Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 54. APAC Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 55. China Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 59. India Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 61. ChinaTaiwan Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Mucopolysaccharidosis II Sales Market Share by Country in 2025
Figure 63. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2020-2025)
Figure 64. Europe Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 65. Europe Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 66. Germany Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 67.France Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 73. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 74. Egypt Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 77.Turkey Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II in 2025
Figure 80. Manufacturing Process Analysis of Mucopolysaccharidosis II
Figure 81. Industry Chain Structure of Mucopolysaccharidosis II
Figure 82. Channels of Distribution
Figure 83. Global Mucopolysaccharidosis II Sales MarketForecast by Region (2026-2031)
Figure 84. Global Mucopolysaccharidosis II Revenue Market ShareForecast by Region (2026-2031)
Figure 85. Global Mucopolysaccharidosis II Sales Market ShareForecast byType (2026-2031)
Figure 86. Global Mucopolysaccharidosis II Revenue Market ShareForecast byType (2026-2031)
Figure 87. Global Mucopolysaccharidosis II Sales Market ShareForecast by Application (2026-2031)
Figure 88. Global Mucopolysaccharidosis II Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mucopolysaccharidosis II Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mucopolysaccharidosis II by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mucopolysaccharidosis II by Country/Region, 2020, 2024 & 2031
2.2 Mucopolysaccharidosis II Segment by Type
2.2.1 JR-141
2.2.2 EGT-301
2.2.3 DUOC-01
2.2.4 AGT-182
2.2.5 JR-032
2.2.6 Others
2.3 Mucopolysaccharidosis II Sales by Type
2.3.1 Global Mucopolysaccharidosis II Sales Market Share by Type (2020-2025)
2.3.2 Global Mucopolysaccharidosis II Revenue and Market Share by Type (2020-2025)
2.3.3 Global Mucopolysaccharidosis II Sale Price by Type (2020-2025)
2.4 Mucopolysaccharidosis II Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Center
2.4.4 Others
2.5 Mucopolysaccharidosis II Sales by Application
2.5.1 Global Mucopolysaccharidosis II Sale Market Share by Application (2020-2025)
2.5.2 Global Mucopolysaccharidosis II Revenue and Market Share by Application (2020-2025)
2.5.3 Global Mucopolysaccharidosis II Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Mucopolysaccharidosis II Breakdown Data by Company
3.1.1 Global Mucopolysaccharidosis II Annual Sales by Company (2020-2025)
3.1.2 Global Mucopolysaccharidosis II Sales Market Share by Company (2020-2025)
3.2 Global Mucopolysaccharidosis II Annual Revenue by Company (2020-2025)
3.2.1 Global Mucopolysaccharidosis II Revenue by Company (2020-2025)
3.2.2 Global Mucopolysaccharidosis II Revenue Market Share by Company (2020-2025)
3.3 Global Mucopolysaccharidosis II Sale Price by Company
3.4 Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mucopolysaccharidosis II Product Location Distribution
3.4.2 Players Mucopolysaccharidosis II Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
4.1 World Historic Mucopolysaccharidosis II Market Size by Geographic Region (2020-2025)
4.1.1 Global Mucopolysaccharidosis II Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mucopolysaccharidosis II Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mucopolysaccharidosis II Market Size by Country/Region (2020-2025)
4.2.1 Global Mucopolysaccharidosis II Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mucopolysaccharidosis II Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mucopolysaccharidosis II Sales Growth
4.4 APAC Mucopolysaccharidosis II Sales Growth
4.5 Europe Mucopolysaccharidosis II Sales Growth
4.6 Middle East & Africa Mucopolysaccharidosis II Sales Growth
5 AMERICAS
5.1 Americas Mucopolysaccharidosis II Sales by Country
5.1.1 Americas Mucopolysaccharidosis II Sales by Country (2020-2025)
5.1.2 Americas Mucopolysaccharidosis II Revenue by Country (2020-2025)
5.2 Americas Mucopolysaccharidosis II Sales by Type (2020-2025)
5.3 Americas Mucopolysaccharidosis II Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mucopolysaccharidosis II Sales by Region
6.1.1 APAC Mucopolysaccharidosis II Sales by Region (2020-2025)
6.1.2 APAC Mucopolysaccharidosis II Revenue by Region (2020-2025)
6.2 APAC Mucopolysaccharidosis II Sales by Type (2020-2025)
6.3 APAC Mucopolysaccharidosis II Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mucopolysaccharidosis II by Country
7.1.1 Europe Mucopolysaccharidosis II Sales by Country (2020-2025)
7.1.2 Europe Mucopolysaccharidosis II Revenue by Country (2020-2025)
7.2 Europe Mucopolysaccharidosis II Sales by Type (2020-2025)
7.3 Europe Mucopolysaccharidosis II Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mucopolysaccharidosis II by Country
8.1.1 Middle East & Africa Mucopolysaccharidosis II Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mucopolysaccharidosis II Revenue by Country (2020-2025)
8.2 Middle East & Africa Mucopolysaccharidosis II Sales by Type (2020-2025)
8.3 Middle East & Africa Mucopolysaccharidosis II Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II
10.3 Manufacturing Process Analysis of Mucopolysaccharidosis II
10.4 Industry Chain Structure of Mucopolysaccharidosis II
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mucopolysaccharidosis II Distributors
11.3 Mucopolysaccharidosis II Customer
12 WORLD FORECAST REVIEW FOR MUCOPOLYSACCHARIDOSIS II BY GEOGRAPHIC REGION
12.1 Global Mucopolysaccharidosis II Market Size Forecast by Region
12.1.1 Global Mucopolysaccharidosis II Forecast by Region (2026-2031)
12.1.2 Global Mucopolysaccharidosis II Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mucopolysaccharidosis II Forecast by Type (2026-2031)
12.7 Global Mucopolysaccharidosis II Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Alexion Pharmaceuticals, Inc.
13.1.1 Alexion Pharmaceuticals, Inc. Company Information
13.1.2 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Alexion Pharmaceuticals, Inc. Main Business Overview
13.1.5 Alexion Pharmaceuticals, Inc. Latest Developments
13.2 AngioChem Inc.
13.2.1 AngioChem Inc. Company Information
13.2.2 AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AngioChem Inc. Main Business Overview
13.2.5 AngioChem Inc. Latest Developments
13.3 ArmaGen Inc.
13.3.1 ArmaGen Inc. Company Information
13.3.2 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 ArmaGen Inc. Main Business Overview
13.3.5 ArmaGen Inc. Latest Developments
13.4 Bioasis Technologies Inc.
13.4.1 Bioasis Technologies Inc. Company Information
13.4.2 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Bioasis Technologies Inc. Main Business Overview
13.4.5 Bioasis Technologies Inc. Latest Developments
13.5 Green Cross Corporation
13.5.1 Green Cross Corporation Company Information
13.5.2 Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
13.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Green Cross Corporation Main Business Overview
13.5.5 Green Cross Corporation Latest Developments
13.6 Inventiva
13.6.1 Inventiva Company Information
13.6.2 Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
13.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Inventiva Main Business Overview
13.6.5 Inventiva Latest Developments
13.7 JCR Pharmaceuticals Co., Ltd.
13.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
13.7.2 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
13.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 JCR Pharmaceuticals Co., Ltd. Main Business Overview
13.7.5 JCR Pharmaceuticals Co., Ltd. Latest Developments
13.8 Laboratorios Del Dr. Esteve S.A.
13.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
13.8.2 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
13.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Laboratorios Del Dr. Esteve S.A. Main Business Overview
13.8.5 Laboratorios Del Dr. Esteve S.A. Latest Developments
13.9 RegenxBio Inc.
13.9.1 RegenxBio Inc. Company Information
13.9.2 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 RegenxBio Inc. Main Business Overview
13.9.5 RegenxBio Inc. Latest Developments
13.10 Sangamo BioSciences, Inc.
13.10.1 Sangamo BioSciences, Inc. Company Information
13.10.2 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
13.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sangamo BioSciences, Inc. Main Business Overview
13.10.5 Sangamo BioSciences, Inc. Latest Developments
13.11 Takeda
13.11.1 Takeda Company Information
13.11.2 Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
13.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Takeda Main Business Overview
13.11.5 Takeda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Mucopolysaccharidosis II Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Mucopolysaccharidosis II Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of JR-141
Table 4. Major Players of EGT-301
Table 5. Major Players of DUOC-01
Table 6. Major Players of AGT-182
Table 7. Major Players of JR-032
Table 8. Major Players of Others
Table 9. Global Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 10. Global Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Table 11. Global Mucopolysaccharidosis II Revenue byType (2020-2025) & ($ million)
Table 12. Global Mucopolysaccharidosis II Revenue Market Share byType (2020-2025)
Table 13. Global Mucopolysaccharidosis II Sale Price byType (2020-2025) & (USD/Pcs)
Table 14. Global Mucopolysaccharidosis II Sale by Application (2020-2025) & (K Pcs)
Table 15. Global Mucopolysaccharidosis II Sale Market Share by Application (2020-2025)
Table 16. Global Mucopolysaccharidosis II Revenue by Application (2020-2025) & ($ million)
Table 17. Global Mucopolysaccharidosis II Revenue Market Share by Application (2020-2025)
Table 18. Global Mucopolysaccharidosis II Sale Price by Application (2020-2025) & (USD/Pcs)
Table 19. Global Mucopolysaccharidosis II Sales by Company (2020-2025) & (K Pcs)
Table 20. Global Mucopolysaccharidosis II Sales Market Share by Company (2020-2025)
Table 21. Global Mucopolysaccharidosis II Revenue by Company (2020-2025) & ($ millions)
Table 22. Global Mucopolysaccharidosis II Revenue Market Share by Company (2020-2025)
Table 23. Global Mucopolysaccharidosis II Sale Price by Company (2020-2025) & (USD/Pcs)
Table 24. Key Manufacturers Mucopolysaccharidosis II Producing Area Distribution and Sales Area
Table 25. Players Mucopolysaccharidosis II Products Offered
Table 26. Mucopolysaccharidosis II Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Mucopolysaccharidosis II Sales by Geographic Region (2020-2025) & (K Pcs)
Table 30. Global Mucopolysaccharidosis II Sales Market Share Geographic Region (2020-2025)
Table 31. Global Mucopolysaccharidosis II Revenue by Geographic Region (2020-2025) & ($ millions)
Table 32. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region (2020-2025)
Table 33. Global Mucopolysaccharidosis II Sales by Country/Region (2020-2025) & (K Pcs)
Table 34. Global Mucopolysaccharidosis II Sales Market Share by Country/Region (2020-2025)
Table 35. Global Mucopolysaccharidosis II Revenue by Country/Region (2020-2025) & ($ millions)
Table 36. Global Mucopolysaccharidosis II Revenue Market Share by Country/Region (2020-2025)
Table 37. Americas Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
Table 38. Americas Mucopolysaccharidosis II Sales Market Share by Country (2020-2025)
Table 39. Americas Mucopolysaccharidosis II Revenue by Country (2020-2025) & ($ millions)
Table 40. Americas Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 41. Americas Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 42. APAC Mucopolysaccharidosis II Sales by Region (2020-2025) & (K Pcs)
Table 43. APAC Mucopolysaccharidosis II Sales Market Share by Region (2020-2025)
Table 44. APAC Mucopolysaccharidosis II Revenue by Region (2020-2025) & ($ millions)
Table 45. APAC Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 46. APAC Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 47. Europe Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
Table 48. Europe Mucopolysaccharidosis II Revenue by Country (2020-2025) & ($ millions)
Table 49. Europe Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 50. Europe Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Mucopolysaccharidosis II Sales by Country (2020-2025) & (K Pcs)
Table 52. Middle East & Africa Mucopolysaccharidosis II Revenue Market Share by Country (2020-2025)
Table 53. Middle East & Africa Mucopolysaccharidosis II Sales byType (2020-2025) & (K Pcs)
Table 54. Middle East & Africa Mucopolysaccharidosis II Sales by Application (2020-2025) & (K Pcs)
Table 55. Key Market Drivers & Growth Opportunities of Mucopolysaccharidosis II
Table 56. Key Market Challenges & Risks of Mucopolysaccharidosis II
Table 57. Key IndustryTrends of Mucopolysaccharidosis II
Table 58. Mucopolysaccharidosis II Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Mucopolysaccharidosis II Distributors List
Table 61. Mucopolysaccharidosis II Customer List
Table 62. Global Mucopolysaccharidosis II SalesForecast by Region (2026-2031) & (K Pcs)
Table 63. Global Mucopolysaccharidosis II RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Americas Mucopolysaccharidosis II SalesForecast by Country (2026-2031) & (K Pcs)
Table 65. Americas Mucopolysaccharidosis II Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. APAC Mucopolysaccharidosis II SalesForecast by Region (2026-2031) & (K Pcs)
Table 67. APAC Mucopolysaccharidosis II Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 68. Europe Mucopolysaccharidosis II SalesForecast by Country (2026-2031) & (K Pcs)
Table 69. Europe Mucopolysaccharidosis II RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Middle East & Africa Mucopolysaccharidosis II SalesForecast by Country (2026-2031) & (K Pcs)
Table 71. Middle East & Africa Mucopolysaccharidosis II RevenueForecast by Country (2026-2031) & ($ millions)
Table 72. Global Mucopolysaccharidosis II SalesForecast byType (2026-2031) & (K Pcs)
Table 73. Global Mucopolysaccharidosis II RevenueForecast byType (2026-2031) & ($ millions)
Table 74. Global Mucopolysaccharidosis II SalesForecast by Application (2026-2031) & (K Pcs)
Table 75. Global Mucopolysaccharidosis II RevenueForecast by Application (2026-2031) & ($ millions)
Table 76. Alexion Pharmaceuticals, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 77. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 78. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 79. Alexion Pharmaceuticals, Inc. Main Business
Table 80. Alexion Pharmaceuticals, Inc. Latest Developments
Table 81. AngioChem Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 82. AngioChem Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 83. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 84. AngioChem Inc. Main Business
Table 85. AngioChem Inc. Latest Developments
Table 86. ArmaGen Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 87. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 88. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 89. ArmaGen Inc. Main Business
Table 90. ArmaGen Inc. Latest Developments
Table 91. BioasisTechnologies Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 92. BioasisTechnologies Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 93. BioasisTechnologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 94. BioasisTechnologies Inc. Main Business
Table 95. BioasisTechnologies Inc. Latest Developments
Table 96. Green Cross Corporation Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 97. Green Cross Corporation Mucopolysaccharidosis II Product Portfolios and Specifications
Table 98. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Green Cross Corporation Main Business
Table 100. Green Cross Corporation Latest Developments
Table 101. Inventiva Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 102. Inventiva Mucopolysaccharidosis II Product Portfolios and Specifications
Table 103. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Inventiva Main Business
Table 105. Inventiva Latest Developments
Table 106. JCR Pharmaceuticals Co., Ltd. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 107. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 108. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. JCR Pharmaceuticals Co., Ltd. Main Business
Table 110. JCR Pharmaceuticals Co., Ltd. Latest Developments
Table 111. Laboratorios Del Dr. Esteve S.A. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 112. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 113. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. Laboratorios Del Dr. Esteve S.A. Main Business
Table 115. Laboratorios Del Dr. Esteve S.A. Latest Developments
Table 116. RegenxBio Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 117. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 118. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. RegenxBio Inc. Main Business
Table 120. RegenxBio Inc. Latest Developments
Table 121. Sangamo BioSciences, Inc. Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 122. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolios and Specifications
Table 123. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. Sangamo BioSciences, Inc. Main Business
Table 125. Sangamo BioSciences, Inc. Latest Developments
Table 126.Takeda Basic Information, Mucopolysaccharidosis II Manufacturing Base, Sales Area and Its Competitors
Table 127.Takeda Mucopolysaccharidosis II Product Portfolios and Specifications
Table 128.Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 129.Takeda Main Business
Table 130.Takeda Latest Developments
LIST OFFIGURES
Figure 1. Picture of Mucopolysaccharidosis II
Figure 2. Mucopolysaccharidosis II Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mucopolysaccharidosis II Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Mucopolysaccharidosis II Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Mucopolysaccharidosis II Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Mucopolysaccharidosis II Sales Market Share by Country/Region (2024)
Figure 10. Mucopolysaccharidosis II Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of JR-141
Figure 12. Product Picture of EGT-301
Figure 13. Product Picture of DUOC-01
Figure 14. Product Picture of AGT-182
Figure 15. Product Picture of JR-032
Figure 16. Product Picture of Others
Figure 17. Global Mucopolysaccharidosis II Sales Market Share byType in 2025
Figure 18. Global Mucopolysaccharidosis II Revenue Market Share byType (2020-2025)
Figure 19. Mucopolysaccharidosis II Consumed in Hospital
Figure 20. Global Mucopolysaccharidosis II Market: Hospital (2020-2025) & (K Pcs)
Figure 21. Mucopolysaccharidosis II Consumed in Clinic
Figure 22. Global Mucopolysaccharidosis II Market: Clinic (2020-2025) & (K Pcs)
Figure 23. Mucopolysaccharidosis II Consumed in Research Center
Figure 24. Global Mucopolysaccharidosis II Market: Research Center (2020-2025) & (K Pcs)
Figure 25. Mucopolysaccharidosis II Consumed in Others
Figure 26. Global Mucopolysaccharidosis II Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Mucopolysaccharidosis II Sale Market Share by Application (2024)
Figure 28. Global Mucopolysaccharidosis II Revenue Market Share by Application in 2025
Figure 29. Mucopolysaccharidosis II Sales by Company in 2025 (K Pcs)
Figure 30. Global Mucopolysaccharidosis II Sales Market Share by Company in 2025
Figure 31. Mucopolysaccharidosis II Revenue by Company in 2025 ($ millions)
Figure 32. Global Mucopolysaccharidosis II Revenue Market Share by Company in 2025
Figure 33. Global Mucopolysaccharidosis II Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Mucopolysaccharidosis II Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 36. Americas Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 37. APAC Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 38. APAC Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 39. Europe Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 40. Europe Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Mucopolysaccharidosis II Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Mucopolysaccharidosis II Revenue 2020-2025 ($ millions)
Figure 43. Americas Mucopolysaccharidosis II Sales Market Share by Country in 2025
Figure 44. Americas Mucopolysaccharidosis II Revenue Market Share by Country (2020-2025)
Figure 45. Americas Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 46. Americas Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 47. United States Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Mucopolysaccharidosis II Sales Market Share by Region in 2025
Figure 52. APAC Mucopolysaccharidosis II Revenue Market Share by Region (2020-2025)
Figure 53. APAC Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 54. APAC Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 55. China Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 59. India Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 61. ChinaTaiwan Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Mucopolysaccharidosis II Sales Market Share by Country in 2025
Figure 63. Europe Mucopolysaccharidosis II Revenue Market Share by Country (2020-2025)
Figure 64. Europe Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 65. Europe Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 66. Germany Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 67.France Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Mucopolysaccharidosis II Sales Market Share byType (2020-2025)
Figure 73. Middle East & Africa Mucopolysaccharidosis II Sales Market Share by Application (2020-2025)
Figure 74. Egypt Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 77.Turkey Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Mucopolysaccharidosis II Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II in 2025
Figure 80. Manufacturing Process Analysis of Mucopolysaccharidosis II
Figure 81. Industry Chain Structure of Mucopolysaccharidosis II
Figure 82. Channels of Distribution
Figure 83. Global Mucopolysaccharidosis II Sales MarketForecast by Region (2026-2031)
Figure 84. Global Mucopolysaccharidosis II Revenue Market ShareForecast by Region (2026-2031)
Figure 85. Global Mucopolysaccharidosis II Sales Market ShareForecast byType (2026-2031)
Figure 86. Global Mucopolysaccharidosis II Revenue Market ShareForecast byType (2026-2031)
Figure 87. Global Mucopolysaccharidosis II Sales Market ShareForecast by Application (2026-2031)
Figure 88. Global Mucopolysaccharidosis II Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Mobile Phone Insurance Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
102 pages
Global Mobile Phone Design Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
November 2025
84 pages
Global Mobile Phone Manufacture Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
91 pages
Global Mobile Phone Application Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
September 2024
136 pages
